| scholarly article | Q13442814 |
| P2093 | author name string | P. W. Kalivas | |
| P. Duffy | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| enkephalin | Q325101 | ||
| nucleus accumbens | Q1476178 | ||
| P304 | page(s) | 2940-2949 | |
| P577 | publication date | 1990-09-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens | |
| P478 | volume | 10 |
| Q36935360 | (+)-Morphine attenuates the (-)-morphine-produced conditioned place preference and the mu-opioid receptor-mediated dopamine increase in the posterior nucleus accumbens of the rat. |
| Q46595569 | Activation of central neurotensin receptors reinstates cocaine seeking in the rat: modulation by a D1/D5, but not D2/D3, receptor antagonist |
| Q35782990 | Altered neurotensin mrna expression in mice lacking the dopamine transporter |
| Q49617041 | Antagonism of neurotensin receptors in the ventral tegmental area decreases methamphetamine self-administration and methamphetamine seeking in mice. |
| Q43803231 | Antidepressant-like effect of neurotensin administered in the ventral tegmental area in the forced swimming test |
| Q48186453 | Blockade of neurotensin-induced motor activity by inhibition of protein kinase |
| Q44341298 | Central d-Ala2-Met5-enkephalinamide μ/δ-opioid receptor activation blocks behavioral sensitization to cholecystokinin in CD-1 mice |
| Q44341292 | Central d-Ala2-Met5-enkephalinamide μ/δ-opioid receptor activation reverses the anxiogenic-like properties of cholecystokinin on locomotor and rearing activity in CD-1 mice |
| Q44394945 | Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats |
| Q56337210 | Chapter 1 The cellular framework for chemical signalling in the nucleus accumbens |
| Q73930962 | Comparative effects of neurotensin, neurotensin(8-13) and [D-Tyr(11)]neurotensin applied into the ventral tegmental area on extracellular dopamine in the rat prefrontal cortex and nucleus accumbens |
| Q48399646 | Desensitization and enhancement of neurotensin/neuromedin N mRNA responses in subsets of rat caudate-putamen neurons following multiple administrations of haloperidol |
| Q55265773 | Determination of neurotensin projections to the ventral tegmental area in mice. |
| Q42458836 | Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: a combined in vivo electrochemical and electrophysiological study. |
| Q50189472 | Diverse actions of the modulatory peptide neurotensin on central synaptic transmission. |
| Q30456105 | Diverse roles of neurotensin agonists in the central nervous system |
| Q33704191 | Does neurotensin mediate the effects of antipsychotic drugs? |
| Q48822423 | Dopamine and conditioned reinforcement. II. Contrasting effects of amphetamine microinjection into the nucleus accumbens with peptide microinjection into the ventral tegmental area |
| Q64386018 | Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity |
| Q48175609 | Effects of morphine on metabolism of dopamine and serotonin in brains of alcohol-preferring AA and alcohol-avoiding ANA rats |
| Q30426586 | Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders. |
| Q34382515 | Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization |
| Q55266051 | Enkephalin as a Pivotal Player in Neuroadaptations Related to Psychostimulant Addiction. |
| Q73964518 | Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization |
| Q48522950 | Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens |
| Q48527120 | Facilitation of brain stimulation reward by mesencephalic injections of neurotensin-(1–13) |
| Q67831445 | Gabaergic and Enkephalinergic Regulation of Locomotion in the Ventral Pallidum: Involvement of the Mesolimbic Dopamine System |
| Q27014840 | Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders |
| Q43629528 | High-affinity neurotensin receptors in the rat nucleus accumbens: subcellular targeting and relation to endogenous ligand. |
| Q49724180 | Identification of Neurotensin Receptor Expressing Cells in the Ventral Tegmental Area across the Lifespan. |
| Q41074381 | In vivo analysis of the role of dopamine in stimulant and opiate self-administration. |
| Q43962661 | Interaction between neuropeptide FF and opioids in the ventral tegmental area in the behavioral response to novelty |
| Q51551698 | Intra-ventral tegmental area administration of H7 delays, but does not prevent the development of cocaine-induced sensitization. |
| Q44339773 | Involvement of the nucleus accumbens in stimulation of the immune response in rats after activation of opioid mu receptors with DAGO. |
| Q48827453 | Involvement of the rat caudate nucleus in the immunostimulatory effect of DAGO. |
| Q48101436 | Isolation rearing impairs the reinforcing efficacy of intravenous cocaine or intra-accumbens d-amphetamine: impaired response to intra-accumbens D1 and D2/D3 dopamine receptor antagonists |
| Q36787595 | Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents |
| Q37379975 | Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity |
| Q48170088 | Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer. |
| Q42081496 | Methamphetamine-induced behavioral sensitization in mice: alterations in mu-opioid receptor |
| Q43664466 | Neurons of origin of the neurotensinergic plexus enmeshing the ventral tegmental area in rat: retrograde labeling and in situ hybridization combined |
| Q35152140 | Neurotensin agonists: possible drugs for treatment of psychostimulant abuse |
| Q28345182 | Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice |
| Q37168720 | Neurotensin in the ventral pallidum increases extracellular gamma-aminobutyric acid and differentially affects cue- and cocaine-primed reinstatement |
| Q24634249 | Neurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preference |
| Q46638594 | Neurotensin, N-acetyl-aspartylglutamate and beta-endorphin modulate [3H]dopamine release from guinea pig nucleus accumbens, prefrontal cortex and caudate-putamen |
| Q37126806 | Novel research translates to clinical cases of schizophrenic and cocaine psychosis. |
| Q35809600 | Nucleus accumbens neuronal activity in freely behaving rats is modulated following acute and chronic methylphenidate administration |
| Q43960792 | Presynaptic action of neurotensin on cultured ventral tegmental area dopaminergic neurones |
| Q33493599 | Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function |
| Q44071660 | Presynaptic mu-opioid receptors regulate a late step of the secretory process in rat ventral tegmental area GABAergic neurons |
| Q48873794 | Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. |
| Q48684213 | Repeated activation of neurotensin receptors sensitizes to the stimulant effect of amphetamine |
| Q48320971 | Repeated injection of GBR 12909, but not cocaine or WIN 35,065-2, into the ventral tegmental area induces behavioral sensitization |
| Q48465663 | Repeated ventral midbrain neurotensin injections sensitize to amphetamine-induced locomotion and ERK activation: A role for NMDA receptors |
| Q44795521 | Role of calcium in neurotensin-evoked enhancement in firing in mesencephalic dopamine neurons. |
| Q47172685 | Role of central neurotensin in regulating feeding: Implications for the development and treatment of body weight disorders |
| Q38530804 | Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine |
| Q34322020 | The cellular framework for chemical signalling in the nucleus accumbens |
| Q43846382 | The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitisation in mice. |
| Q36544566 | The role of neurotensin in central nervous system pathophysiology: what is the evidence? |
| Q34668388 | To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance |
Search more.